期刊文献+

梗阻性不稳定膀胱模型的尿流动力学评价 被引量:1

Evaluation on urodynamics of the partial bladder outlet obstruction model
暂未订购
导出
摘要 目的:建立兔不全梗阻性不稳定膀胱动物模型,并观察其尿流动力学的变化。方法:取雄性成年新西兰大白兔30只,随机分为对照(假手术)组和梗阻组各15只。不全梗阻性手术后第8周,在氯胺酮和氟哌利多全麻下行尿流动力学等检侧。结果:梗阻8周后,梗阻组兔的膀胱尿流动力学主要参数较对照组有显著变化。梗阻组不稳定膀胱的发生率为60%。该膀胱出口不全梗阻动物模型无论从膀胱的病理或尿流动力学的改变,均与人类慢性膀胱出口不全梗阻类似。结论:这一动物模型的成功建立,为进一步研究人类慢性不全梗阻性不稳定膀胱疾病的病理、病理生理变化及治疗提供了一个平台。 Objective: To establish a rabbit unstable bladder and Partial Bladder Outlet Obstruction (BOO) model, and to study on urodynamic changes. Methods: 30 male New Zealand rabbits were divided into control group and operative group. After 8 weeks, urodynamic changes were determined after they were anaesthetized by ketamine and droperidol. Results: Prominent changes of Main urodynamic parameters were found between the operative group and control group. The incidence rate of unstable bladder was 60%. Conclusion: The method of establishing rabbit model of Partial BOO is successful. It provides a platform for the study on the changes of pathology and pathophysiology of human chronic partial BOO and treatment of this kind of diseases.
出处 《医学研究生学报》 CAS 2005年第7期603-605,共3页 Journal of Medical Postgraduates
基金 中国博士后科学基金资助项目(批准号:2002032189)
关键词 膀胱出口不全梗阻 不稳定膀胱 尿流动力学 Rabbit Partial bladder outlet obstruction Unstable bladder Urodynamics
  • 相关文献

参考文献10

  • 1Verhamme KMC, Dieleman JP, Bleumink GS et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care-The Triumph Project [J]. Eur Urol, 2002, 42(4):323-328.
  • 2Clifford GM, Logie J, Farmer RDT. How do symptoms indicative of BPH progress in real life practice? [J]. UK Exper Eur Urol, 2000, 38(Suppl 1):48-53.
  • 3Machadomg,Yoo JJ,Atala A. Defunctionalized bladders: effects before and after refunctionalization in an animal mode [J]. J Urol, 2000, 164(3 Pt 2): 1002-1007.
  • 4Matsumoto S, Chichester P, Kogan BA et al. Structural and vascular response of normal and obstructed rabbit whole bladders to distension [J]. Urology, 2003 , 62(6):1129-1133.
  • 5程文 ,葛京平 ,周四维 ,高建平 .膀胱过度活动的药物治疗进展[J].医学研究生学报,2004,17(2):167-168. 被引量:4
  • 6van Venrooij GE, Van Melick HH, Eckhardt MD et al. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate [J]. J Urol, 2002, 168(2):605-609.
  • 7Celayir S, Ilce Z, Dervisoglu S. The sex hormone receptors in the bladder in childhood - I: preliminary report in male subjects [J]. Eur J Pediatr Surg, 2002, 12(5):312-317.
  • 8Chou EC, Whitbeck C, Borow A et al. Inhibition of hyperreflexia by vaginally administered oxybutynin: a novel rabbit model [J]. J Urol, 2004,171(2 Pt 1): 958 -962.
  • 9金锡御 宋波.临床尿动力学[M].北京:人民卫生出版社,2003.63.
  • 10龚隽,高建平,程文.膀胱出口不全梗阻兔的尿流动力学实验研究[J].医学研究生学报,2005,18(2):185-185. 被引量:2

二级参考文献18

  • 1[1]Chancellor MB, De Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways that we treat the overactive bladder[J].J Urol ,1999,162(1): 3-11.
  • 2[2]Larsson G, Hallen B, Nilvebrandt L. Tolterodine in the tretment of overative ldder : an analysis of the pooled phase Ⅱefficacy and safety data[J]. Urology,1999,53(5):990-990.
  • 3[3]Gupta SK, Sathyan G. Pharmacokinetics of an oral once a day controlled release oxybutnin formulation compared with immediate release oxybutnin[J]. J Clin Pharmacol,1999,39(3):289-296.
  • 4[4]Chancellor MB, Appell RA , Sathyan G et al. Effect of controlled release oxybutynin and tolterodine on salivary output[J]. Neurourol Urodyn, 2000,19(1):94.
  • 5[5]Frolich G, Burmeister S, Wiedemann A et al. Intravesical trospium chloride , oxybutynin, and verapimil for relaxation of detrusor muscle: placebo controlled, randomized clinical tial in Germany[J]. Arzneimittelforschung,1998,48(4):486-491.
  • 6[6]Rosario DJ, Cutinha PE, Chapple CR et al. The effects of ingle dose darifenicin on cystometric parameters and salivary flow in patients with urge incontinence secondary to detrusor instability[J].Eur Urol,1996,30(3):240.
  • 7[7]Phelan MW, Yoshimura N, Goins WF et al. Nerve growth factor(NGF) gene therapy improves rat diabetic cystopathy, but does not increase pain sensation[J]. J Urol,2000,163(3):245-248.
  • 8[8]Palmer LS, Zebold K, Firlt CF et al. Complications Of intravesical oxybutnin chloride therapy in the peditric myelomeningocele population[J]. J Urol,1997,157(2):638-640.
  • 9[9]Singh SS, Smith KM, Brown DM. Drug retention following intravesical delievery of fluorouracil therapeutic adhesive in C3H mouse bladderc[J]. Anticancer Drugs,1996,7(4):507-511.
  • 10[10]Dasgupta P, Chandiramani V, Parkinson MC et al. Treating the human bladder with capsaicin : isit safe?[J] Eur Urol,1998,33(1):28-32.

共引文献7

同被引文献7

  • 1程文,高建平,张征宇.梗阻性不稳定膀胱逼尿肌细胞内Ca^(2+)的变化及意义[J].医学研究生学报,2005,18(9):787-789. 被引量:3
  • 2Abrams P,Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function : report from the standardization sub-committee of the International Continence Society [ J ].Urology, 2003,61:37-49.
  • 3Rosen R,Altwein J,Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction : the multinational survey of the aging male (MSAM-7)[J]. Eur Urol, 2003,44:637-649.
  • 4Greenland J, Brading A. The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs[J]. J Urol,2001, 165( 1 ) :245-248.
  • 5Janknegt RA, Hassouna MM, Siegel SW, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence[J]. Eur Urol,2001, 39:101-106.
  • 6Anderson JB,Rcehrbom CG, Schalken JA, et al. The progression of benign prostatic hyperplasia:examining the evidence and determining the risk[ J]. Eur Urol, 2001,39:390-399.
  • 7McConnell JD, Roehbom CG, Bautista OM,et ad. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia [ J ]. N Engl J Med, 2003,349:2387-2398.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部